logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • China related news
    • Insights
    • Client Press Releases
    • Client Coverage
  • CEO Interviews
  • Clients
    • Public Companies
    • Private Companies
    • In-depth Analysis
    • Trusted Advisors
      • Mortgage Broker
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • Events
    • GCFF Conference
    • Past GCFF Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference

February 18, 2021

RepliCel Closes First Tranche of Strategic Investment Commitment

February 10, 2021

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel CEO Provides Corporate Update

February 8, 2021

医疗保健精选——辉瑞公司有望5月前向美国供应2亿剂新冠疫苗;Cassava的阿尔茨海默病试验得出积极数据

Healthcare Roundup – Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May; Cassava surges after favorable trial data for simufilam in Alzheimer’s disease

February 3, 2021

Life Science

Healthcare Roundup – Illumina surges after patent win; announces collaboration in China; BioCryst climbs after being named ‘the most undervalued stock in the market

February 1, 2021

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement

January 25, 2021

Life Science

医疗保健精选——Moderna日本早期新冠疫苗试验接种首位参与者;基因编辑公司股价攀升

Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest

January 21, 2021

Life Science

Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout

January 12, 2021

Life Science

医疗保健精选——杰富瑞上调CVS药店的目标股价,软银入股生物科技公司Pacific Biosciences

Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences

January 9, 2021

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

December 22, 2020

Life Science

Healthcare Roundup – U.S. prepares for mass inoculations as COVID-19 vaccine rolls out, Bahrain OK’s Chinese COVID-19 vaccine for use

December 14, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces Adoption of Advance Notice Bylaw and Shareholder Rights Plan as well as Transitions in its Board of Directors

December 11, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis

November 27, 2020

Life Science

医疗保健精选——辉瑞和BioNTech新冠疫苗最终有效率达95%;FDA批准首个在家使用的新冠病毒试剂

Healthcare Roundup – Pfizer (PFE), BioNTech (BNTX) vaccine is 95% effective in final analysis; FDA authorizes first at-home rapid COVID-19 test

November 18, 2020

Life Science

医疗保健精选——Sorrento申请新冠抗体鼻喷雾剂的新药试验;欧盟与辉瑞和BioNTech接近达成新冠疫苗供应协议

Healthcare Roundup – Sorrento files IND for antibody nasal spray for COVID-19; EU next to reach deal for Pfizer, BioNTech vaccine

November 12, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership

November 10, 2020

Life Science

Healthcare Roundup – Futures add to big gains on vaccine hopes after Pfizer interim data, China vaccine trial suspended after ‘severe adverse event’

November 9, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Closing of Debt Settlement

October 28, 2020

Life Science

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Terms of Use
  • Content Partner
  • Chinese Investor Relations Outreach Program
  • About Us
  • Contact Us

© 2021 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok